ClinicalTrials.Veeva

Menu

GlowTest COVID-19 Antigen Home Test Kit QRI Use Study

A

Arion Bio

Status

Completed

Conditions

Covid 19

Treatments

Diagnostic Test: GlowTest COVID-19 Antigen Home Test

Study type

Interventional

Funder types

Industry

Identifiers

NCT05140005
AB-001-01

Details and patient eligibility

About

The objective of the study is to determine the usability of the GlowTest COVID-19 Antigen Home Test in a simulated home use environment. This is an open label study to evaluate the usability of the GlowTest COVID-19 Antigen Home Test using information from the Quick Reference Instructions and website.

Full description

The purpose of this study is to evaluate the usability of the GlowTest COVID-19 Antigen Home Test in Home Use. The Arion Bio GlowTest COVID-19 Antigen Home Test is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens from individuals with or without symptoms or other epidemiological reasons to suspect a COVID-19 infection. The test is intended for non-prescription home use with self-collected direct anterior nares swab samples from individuals ages 14 years and older or adult collected anterior nares swab samples from individuals aged 2 to 13. The objective of the study is to determine the usability of the GlowTest COVID-19 Antigen Home Test in a simulated home use environment. This is an open label study to evaluate the usability of the GlowTest COVID-19 Antigen Home Test using information from the Quick Reference Instructions and website.

30 subjects (including both English speaking and Spanish speaking) will be split evenly into two sections: 15 participants testing themselves and 15 participants testing another person (child). There will be one testing site in the United States (US).

Enrollment

33 patients

Sex

All

Ages

2+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • An Institutional Review Board (IRB) approved informed consent/assent is signed and dated prior to any study-related activities.
  • Males and females ages 2 and older.
  • Subject is willing to provide a self-collected nasal swab sample. (If under the age of 14, the sample will be collected by an adult.)
  • Subject agrees to complete all aspects of the study

Exclusion criteria

  • Subject has a visual impairment that cannot be restored with glasses or contact lenses.
  • Subject has prior medical or laboratory training.
  • Subject uses home diagnostics, e.g., glucose meters, HIV tests.
  • Subject has prior experience with home COVID test kits.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

33 participants in 2 patient groups

15 subjects testing themselves
Other group
Description:
15 subjects will use the Glow Test Kit to test themselves for Covid 19.
Treatment:
Diagnostic Test: GlowTest COVID-19 Antigen Home Test
15 subjects testing someone else
Other group
Description:
15 subjects will use the Glow Test Kit to test someone else (a child) for Covid 19.
Treatment:
Diagnostic Test: GlowTest COVID-19 Antigen Home Test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems